Extracellular Vesicles From Multiple Sclerosis White Matter Exhibit Synaptic, Mitochondrial, Complement and Ageing‐Related Pathway Dysregulation
Journal of Extracellular Vesicles · 2025
DOI: 10.1002/jev2.70197 ↗At a glance
Journal article in Journal of Extracellular Vesicles, 2025. Written by Larissa Jank and 10 co-authors. Institution: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA. Major MEDLINE topics: Extracellular Vesicles, White Matter, Multiple Sclerosis, Mitochondria. Cited 8 times so far (Crossref); 77 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Myelin Repair Foundation, National Multiple Sclerosis Society, Genentech.
Abstract (original language)
Extracellular vesicles (EVs) are increasingly recognized as mediators of central nervous system (CNS) function and pathologies, including multiple sclerosis (MS). While plasma‐derived EVs have been explored as biomarkers in MS, little is known about EVs in CNS tissue. Here, we characterize EVs from postmortem normal‐appearing white matter (NAWM) of MS and control brains. EVs were separated by differential centrifugation followed by size exclusion chromatography and characterized using nanoflow cytometry, single‐particle reflectance imaging sensing (SP‐IRIS) and transmission electron microscopy. EV size, yield and morphology did not differ significantly between MS and control samples. Despite the small sample size ( n = 4 per group), proteomic analyses revealed downregulation of synaptic and mitochondrial proteins and upregulation of complement and inflammatory proteins and pathways in MS NAWM EVs. This suggests that EVs reflect ongoing synaptic pathology, metabolic dysfunction and CNS‐compartmentalized inflammation and that they may actively contribute to these pathological processes. Deconvolution analyses suggest a shift in EV cellular origin, with an increased astrocytic and decreased neuronal EV contribution in MS. Several proteomic changes we observed in CNS‐derived EVs have also been reported in circulating EVs of people with MS, establishing this CNS tissue EV study as a valuable resource for identifying biomarker candidates for brain‐derived plasma EV studies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA.
- Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, USA.
- Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, USA.
- Department of Neuroscience, Cleveland Clinic, Cleveland, USA.
- Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, USA.
ORCID profiles: Larissa Jank, Olesia Gololobova
Funding
- Myelin Repair Foundation
- National Multiple Sclerosis Society
- Genentech
Cite
APA
Jank, L., Kumar, M. K. S., Ryu, T., Thapa, R., Gololobova, O., Niepokny, T. D., Calabresi, P. A., Witwer, K., Dutta, R., Na, C. H., & Bhargava, P. (2025). Extracellular Vesicles From Multiple Sclerosis White Matter Exhibit Synaptic, Mitochondrial, Complement and Ageing‐Related Pathway Dysregulation. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.70197
Vancouver
Jank L, Kumar MKS, Ryu T, Thapa R, Gololobova O, Niepokny TD, et al. Extracellular Vesicles From Multiple Sclerosis White Matter Exhibit Synaptic, Mitochondrial, Complement and Ageing‐Related Pathway Dysregulation. Journal of Extracellular Vesicles. 2025. doi:10.1002/jev2.70197
BibTeX
@article{Jank2025,
author = {Jank, Larissa and Kumar, Madathiparambil Kumaran Satheesh and Ryu, Taekyung and Thapa, Rohit and Gololobova, Olesia and Niepokny, Timothy D and Calabresi, Peter A and Witwer, Kenneth and Dutta, Ranjan and Na, Chan Hyun and Bhargava, Pavan},
title = {Extracellular Vesicles From Multiple Sclerosis White Matter Exhibit Synaptic, Mitochondrial, Complement and Ageing‐Related Pathway Dysregulation},
journal = {Journal of Extracellular Vesicles},
year = {2025},
doi = {10.1002/jev2.70197}
}
EUVIMED